NEXGEL, Inc. (NXGL)
Market Cap | 15.69M |
Revenue (ttm) | 3.53M |
Net Income (ttm) | -2.71M |
Shares Out | 5.72M |
EPS (ttm) | -0.48 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 24,347 |
Open | 2.660 |
Previous Close | 2.710 |
Day's Range | 2.660 - 2.830 |
52-Week Range | 1.250 - 3.140 |
Beta | 0.65 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 13, 2024 |
About NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania. [Read more]
Financial Performance
In 2022, NEXGEL's revenue was $2.05 million, an increase of 32.04% compared to the previous year's $1.55 million. Losses were -$4.75 million, 10.1% more than in 2021.
Financial StatementsNews
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, ...
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, ...
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
LANGHORNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, hig...
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
LANGHORNE, Pa., Dec. 11, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, hig...
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Gross profit margin improved sequentially to 28.2% in Q3 as compared to 15.0% in Q2 LANGHORNE, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leadi...
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd
LANGHORNE, Pa., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare an...
NEXGEL to Report Second Quarter 2023 Financial Results on August 14th
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.
NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America
LANGHORNE, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and...
NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th
LANGHORNE, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and...
NEXGEL to Participate in the LD Micro Invitational XIII on June 6th
LANGHORNE, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and ...
NEXGEL to Report First Quarter 2023 Financial Results on May 15th
Management will host a conference call at 4:30 P . M . ET on the same day
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
Management will host a conference call at 4:30 P . M . ET on the same day
NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard
LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthc...
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
LANGHORNE, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthc...
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee
LANGHORNE, Pa. , Jan. 17, 2023 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare ...
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc . (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthc...
NEXGEL Announces Share Repurchase Program
LANGHORNE, Pa. , Dec. 7, 2022 /PRNewswire/ -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare an...
NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET
LANGHORNE, Pa. , Dec. 1, 2022 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare a...
NEXGEL Reports Third Quarter 2022 Financial Results
Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26%
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
Management will host a conference call at 4:30 P . M . ET on the same day
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcar...
SAGE Journals Publishes New Data Revealing NEXGEL's SilverSeal Hydrogel Dressing Improves Postsurgical Scarring
Patients Treated with SilverSeal Experienced Significantly Less Scarring and Improved Skin Functionality Following Surgical Incision
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
LANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthca...